The Scotts Miracle-Gro Company

Equities

SMG

US8101861065

Agricultural Chemicals

Real-time Estimate Cboe BZX 03:53:39 2024-03-28 pm EDT 5-day change 1st Jan Change
74.81 USD +1.63% Intraday chart for The Scotts Miracle-Gro Company +2.59% +17.20%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
North American Morning Briefing : Markets Steady -2- DJ
Raymond James Downgrades Scotts Miracle-Gro to Market Perform From Strong Buy MT
Transcript : The Scotts Miracle-Gro Company Presents at UBS Global Consumer and Retail Conference 2024, Mar-13-2024 03:00 PM
Transcript : The Scotts Miracle-Gro Company Presents at 45th Annual Raymond James Institutional Investors Conference 2024, Mar-04-2024 03:25 PM
Stifel Nicolaus Adjusts Scotts Miracle-Gro Price Target to $65 From $55, Maintains Hold Rating MT
UBS Adjusts Scotts Miracle-Gro Price Target to $63 From $66, Maintains Neutral Rating MT
Scotts Miracle-Gro's Fiscal Q1 Loss Widens, Sales Drop MT
Transcript : The Scotts Miracle-Gro Company, Q1 2024 Earnings Call, Feb 07, 2024
Earnings Flash (SMG) SCOTTS MIRACLE-GRO COMPANY Reports Q1 Revenue $410.4M, vs. Street Est of $412.8M MT
The Scotts Miracle-Gro Company Reports Earnings Results for the First Quarter Ended December 30, 2023 CI
North American Morning Briefing : Stock Futures -2- DJ
The Scotts Miracle-Gro Company Announces Retirement of Nancy Mistretta from Board of Directors CI
Scotts Miracle-Gro Keeps Quarterly Cash Dividend at $0.66 a Share, Payable March 8 to Shareholders of Record Feb. 23 MT
The Scotts Miracle-Gro Company Approves Quarterly Dividend, Payable on March 8, 2024 CI
UBS Adjusts Scotts Miracle-Gro Price Target to $66 From $55, Maintains Neutral Rating MT
Scotts Miracle-Gro Insider Sold Shares Worth $257,390, According to a Recent SEC Filing MT
Transcript : The Scotts Miracle-Gro Company Presents at 2023 Raymond James TMT and Consumer Conference, Dec-04-2023 11:30 AM
Trailblazer Elon Musk pushes a profane new frontier RE
Scotts Miracle-Gro Insider Sold Shares Worth $119,613, According to a Recent SEC Filing MT
The Scotts Miracle-Gro Company Announces Executive Changes CI
Scotts Miracle-Gro Insider Sold Shares Worth $4,278,359, According to a Recent SEC Filing MT
UBS Adjusts Scotts Miracle-Gro Price Target to $55 From $51, Maintains Neutral Rating MT
Scotts Miracle-Gro Shares Extend Gains After Fiscal Q4 Tops Expectations MT
Scotts Miracle-Gro's Shares Rise After Fiscal Q4 Adjusted Net Loss, Sales Beat Analyst Estimates MT
Transcript : The Scotts Miracle-Gro Company, Q4 2023 Earnings Call, Nov 01, 2023
Chart The Scotts Miracle-Gro Company
More charts
The Scotts Miracle-Gro Company is a manufacturer and marketer of branded consumer products for lawn and garden care. The Company's segments include United States (U.S.) Consumer, Hawthorne and Other. The U.S. Consumer segment consists of its consumer lawn and garden business in the United States. Its consumer lawn and garden brands include Scotts and Turf Builder lawn fertilizer and Scotts grass seed products; Miracle-Gro soil, plant food and gardening products; Ortho herbicide and pesticide products, and Tomcat rodent control and animal repellent products. The Hawthorne segment manufactures, markets and distributes lighting, nutrients, growing media, growing environments and hardware products for indoor and hydroponic gardening in North America. Its brands include General Hydroponics, Gavita, Botanicare, Agrolux, Gro Pro, Mother Earth, Grower's Edge, HydroLogic Purification System and Cyco. The Other segment primarily consists of its consumer lawn and garden business in Canada.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
73.61 USD
Average target price
71.14 USD
Spread / Average Target
-3.35%
Consensus
  1. Stock
  2. Equities
  3. Stock The Scotts Miracle-Gro Company - Nyse
  4. News The Scotts Miracle-Gro Company
  5. Scotts Miracle Gro : Raymond James Adjusts Scotts Miracle-Gro's Price Target to $290 From $274, Keeps Strong Buy Rating